Development of the Na+/H+ exchange inhibitor cariporide as a cardioprotective drug: From the laboratory to the GUARDIAN trial

Journal of Thrombosis and Thrombolysis

Volumn 8, Issue 1, 1999, Pages 61-70

  Scholz, Wolfgang ^a   Jessel, Andreas ^a   Albus, Udo ^a  

^a SANOFI   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ION; CARIPORIDE; SODIUM ION;

ACUTE HEART INFARCTION; DRUG MECHANISM; DRUG RESEARCH; DRUG STRUCTURE; HEART ARRHYTHMIA; HEART INFARCTION; HEART MUSCLE CELL; HEART MUSCLE CONTRACTURE; HEART MUSCLE NECROSIS; HEART PROTECTION; HUMAN; HUMAN CELL; MORTALITY; NONHUMAN; PRIORITY JOURNAL; PROTON SODIUM EXCHANGE; REVIEW; THROMBOCYTE;

EID: 0032790859     PISSN: 09295305     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1008998716063     Document Type: Review

References (27)

1. Scholz W, Albus U, Counillon L, et al. Protective effects of HOE 642, a selective sodium hydrogen exchange subtype 1 inhibitor, on cardiac ischaemia and reperfusion. Cardiovasc Res 1995;29:260-268.
2. + exchange. Am J Physiol 1993;265:H2017-H2026.
3. Murphy E, Perlman M, London RE, Steenbergen C. Amiloride delays the ischemia induced rise in cytosolic free calcium. Circ Res 1991;68:1250-1258.
4. Scholz W, Albus U. Potential of selective sodium-hydrogen exchange inhibitors in cardiovascular therapy. Cardiovas Res 1995;29:184-188.
5. + exchange inhibitor and its effects in cardiac ischaemia. Br J. Pharmacol 1993;109:562-568.
6. + changes in ischemia/reperfusion (abstr). J Mol Cell Cardiol 1997;29:A28.
7. 2+ overload in isolated perfused rabbit heart. Circulation 1994;89:2787-2798.
8. Linz W, Albus U, Crause P, Jung W, Weichert A, Schölken BA, Scholz W. Dose dependent reduction of myocardial infarct mass in rabbits by the NHE-1 inhibitor (HOE 642). Clin Exp Hypertensi 198°W:733-749.
9. + exchange during metabolic inhibition prevents reoxygenation-induced hypercontracture in isolated cardiomyocytes. J Am Coll Cardiol 1996;27:293.
10. + exchanger activity does not contribute to protection by ischemic preconditioning in the isolated rat heart. Circulation 1997;96:3617-3625.
11. + exchange inhibitor, HOE 642: Difference from preconditioning in the role of protein kinase C. J Am Coll Cardiol 1997;29:693-701.
12. + exchange inhibitor, on reperfusion ventricular arrhythmias in rat hearts. Eur J Pharmacol 1997;339:121-127.
13. + exchange inhibitor, on ventricular arrhythmias in animal hearts. Eur J Pharmacol 1996;317:309-316.
14. + exchange inhibition with cariporide limits functional impairment due to repetitive ischemia. J Cardiovasc Pharmacol 1998;32: 853-862.
15. + exchange inhibition improves post-transplant myocardial compliance in 4-hour stored donor hearts. Cardiovasc Surg 1998;6:67-75.
16. + exchange inhibition in regionally ischemic, perfused porcine hearts. J Cardiovasc Pharmacol 1997;30:235-240.
17. + exchange. Cardiovasc Res 1997; 35:80-89.
18. + exchange inhibitor cariporide (HOE 642), prevents reperfusions injury in the pig at a high, but not at a low dose. Eur Heart J 1998;19:23, Abstract Supplement.
19. Braunwald E. Shattuck Lecture - Cardiovascular medicine at the turn of the millenium: Triumphs, concerns, and opportunities. N Engl J Med 1997;337:1360-1369.
20. The GUSTO Investigators. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med 1993;329:673-682.
21. The Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO) 2b Investigators. A comparison of recombinant hirudin with heparin for the treatment of acute coronary syndromes. N Engl J Med 1996;335:775-782.
22. The PURSUIT Trial Investigators. Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy. Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes. N Engl J Med 1998;339:436-443.
23. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. Lancet 1988;2:349-358.
24. EPIC Investigators. Use of a monoclonal antibody directed against the platelet receptor glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty. N Engl J Med 1994;330:956-961.
25. th ed. Philadelphia: WB Saunders, 1997:1184-1194.
26. Organization to Assess Strategies for Ischemic Syndromes (OASIS) investigators. Comparison of the effects of two doses of recombinant hirudin compared with heparin in patients with acute myocardial ischemia without ST elevation. Circulation 1997;96:769-777.
27. Drexler H, Rupprecht HJ, Buerke M, et al. A Na+/H + exchange inhibitor improves recovery of ventricular function in patients undergoing coronary angioplasty for acute myocardial infarction. Circulation 1998;98:I344.